Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk
about
Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabsThe intestinal microbiota and susceptibility to infection in immunocompromised patientsCase-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model.The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.Development of a Real-Time PCR Protocol Requiring Minimal Handling for Detection of Vancomycin-Resistant Enterococci with the Fully Automated BD Max SystemAlgorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection.Management of gram-positive bacterial infections in patients with cancer.Antimicrobial stewardship in patients with cancer.Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.The prevention and management of infections due to multidrug resistant organisms in haematology patientsAntibiotic resistance in cancer patients.Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.Evaluation of a chromogenic agar under development to screen for VRE colonization.Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementationWhere is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments.Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012).Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection.Improving the outcome of bloodstream infection in patients with hematological malignancies: looking beyond antibiotics.Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.Vancomycin-resistant enterococci in patients with hematological malignancy: curbing an endemic pathogen.Vancomycin-resistant enterococci infection: not just for the transplanted.Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review.Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
P2860
Q24651085-3E813425-602F-4BC7-A5B5-6727FF78DA3DQ26862848-C2B676AF-C7C4-404A-ACBA-568BC517C869Q33880518-1E5160CA-299B-4B36-884B-BAEFE952E5FEQ35027260-AA89CF25-8190-44BE-8C48-E966A29D14F8Q35400815-E0B1B227-83EB-4B05-861D-7A854E63FA88Q36895914-50F78273-0AA2-4E34-8619-E8958CFDA132Q37218586-ECBE9EB4-0A75-4823-A277-A53B019A232CQ37376490-F548ECF4-7142-4136-B926-74D0890FF4BEQ37899198-15B5ADC5-F4F5-4CBA-BC6C-82564EB493D9Q38073198-0496A178-C5E1-45DC-8000-98E7D353DB40Q38162183-A9B86223-7AD6-4914-97D8-6D86A1635DEEQ38171538-0F9B3197-7DC5-4301-AEBF-481C0F949587Q38212258-78F5ABC9-1B52-4B64-AB24-F2B55D57ECEEQ38264086-3847ED44-73EC-4B6A-9399-5516246CA3DFQ39130315-E9D6EDB1-8054-47D0-96A9-C1F437FA529EQ39133625-F15BEBFD-9F5F-4B0A-8F33-44F26472EF42Q39375402-4AC1FF94-EC18-4A7D-859A-9DACEB3BD13DQ39413092-A2C15BA4-A263-4F69-BEE1-11EA783D67C2Q39761593-916C3523-4A40-4CBA-9E7A-0AE09EAE7F80Q40048433-2E6B8A81-E9F2-42EA-B0E3-8A6AA844D357Q40254524-DB669E23-4F2C-4E04-AAC4-C3C4A9B882C4Q40267813-9F8ADD62-3891-4936-AB18-D0E230DBAA2BQ40274934-757E3A96-DBC1-4D4B-9278-3F811E461A4BQ40573547-81EDF4E4-3641-4E8A-862F-CA6145ABF279Q40707661-262090B7-FC1C-4EFD-BCC5-864374E4A7BDQ41151969-74A5F7B8-77BF-4CF1-9664-913B503E0A0BQ41560706-F89B953F-24B3-4FEB-B954-71CA86314B36Q42247283-D3EF4B22-B2D3-4D53-98A1-AA80F2DB8A41Q42248187-FC97E8A5-1D00-4626-8430-DEACDC7F2D6CQ43184611-B5E084B3-743D-4EB5-84F8-9E962086E334Q43984868-FD146044-5145-457E-BF5F-26CB72D29E7CQ47125142-D17CC8DA-D540-4212-AF8C-D675C6A4BAFEQ49177297-3307D05D-1230-4D09-B4C8-3927A96B24C9Q49446863-1A311CC3-2BFD-41EF-A694-9F731C1012B9Q52651956-BF08BACD-C8A4-4B4A-8B0F-904741208E69
P2860
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@en
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@nl
type
label
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@en
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@nl
prefLabel
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@en
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@nl
P2860
P50
P1476
Vancomycin-resistant Enterococ ...... loid leukemia are at high-risk
@en
P2093
John F Seymour
P2860
P304
P356
10.1111/J.1600-0609.2007.00911.X
P577
2007-07-26T00:00:00Z